221 related articles for article (PubMed ID: 31676720)
1. Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD.
Sun X; Jefferson P; Zhou Q; Angelastro JM; Greene LA
Mol Cancer Res; 2020 Feb; 18(2):216-228. PubMed ID: 31676720
[TBL] [Abstract][Full Text] [Related]
2. Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers.
Greene LA; Zhou Q; Siegelin MD; Angelastro JM
Cells; 2023 Feb; 12(4):. PubMed ID: 36831248
[TBL] [Abstract][Full Text] [Related]
3. Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents.
Zhou Q; Sun X; Pasquier N; Jefferson P; Nguyen TTT; Siegelin MD; Angelastro JM; Greene LA
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065488
[TBL] [Abstract][Full Text] [Related]
4. Dominant-negative ATF5 rapidly depletes survivin in tumor cells.
Sun X; Angelastro JM; Merino D; Zhou Q; Siegelin MD; Greene LA
Cell Death Dis; 2019 Sep; 10(10):709. PubMed ID: 31551409
[TBL] [Abstract][Full Text] [Related]
5. A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers.
Karpel-Massler G; Horst BA; Shu C; Chau L; Tsujiuchi T; Bruce JN; Canoll P; Greene LA; Angelastro JM; Siegelin MD
Clin Cancer Res; 2016 Sep; 22(18):4698-711. PubMed ID: 27126996
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor ATF5: role in neurodevelopment and neural tumors.
Greene LA; Lee HY; Angelastro JM
J Neurochem; 2009 Jan; 108(1):11-22. PubMed ID: 19046351
[TBL] [Abstract][Full Text] [Related]
7. CCAAT/enhancer binding protein alpha, beta and delta gene variants: associations with obesity related phenotypes in the Leeds Family Study.
Bennett CE; Nsengimana J; Bostock JA; Cymbalista C; Futers TS; Knight BL; McCormack LJ; Prasad UK; Riches K; Rolton D; Scarrott T; Barrett JH; Carter AM
Diab Vasc Dis Res; 2010 Jul; 7(3):195-203. PubMed ID: 20460359
[TBL] [Abstract][Full Text] [Related]
8. Advancements in Activating Transcription Factor 5 Function in Regulating Cell Stress and Survival.
Paerhati P; Liu J; Jin Z; Jakoš T; Zhu S; Qian L; Zhu J; Yuan Y
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806136
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of CCAAT/enhancer binding protein-beta and -delta and monocyte chemoattractant protein-1 genes in aortas from hyperinsulinaemic rats.
Sato Y; Nishio Y; Sekine O; Kodama K; Nagai Y; Nakamura T; Maegawa H; Kashiwagi A
Diabetologia; 2007 Feb; 50(2):481-9. PubMed ID: 17180354
[TBL] [Abstract][Full Text] [Related]
10. ATF5 promotes cell survival through transcriptional activation of Hsp27 in H9c2 cells.
Wang H; Lin G; Zhang Z
Cell Biol Int; 2007 Nov; 31(11):1309-15. PubMed ID: 17606386
[TBL] [Abstract][Full Text] [Related]
11. Targeting ATF5 in Cancer.
Angelastro JM
Trends Cancer; 2017 Jul; 3(7):471-474. PubMed ID: 28718401
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin (NPM1/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells.
Liu X; Liu D; Qian D; Dai J; An Y; Jiang S; Stanley B; Yang J; Wang B; Liu X; Liu DX
J Biol Chem; 2012 Jun; 287(23):19599-609. PubMed ID: 22528486
[TBL] [Abstract][Full Text] [Related]
13. Mouse chromosomal location of the CCAAT/enhancer binding proteins C/EBP beta (Cebpb), C/EBP delta (Cebpd), and CRP1 (Cebpe).
Jenkins NA; Gilbert DJ; Cho BC; Strobel MC; Williams SC; Copeland NG; Johnson PF
Genomics; 1995 Jul; 28(2):333-6. PubMed ID: 8530045
[TBL] [Abstract][Full Text] [Related]
14. BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent manner.
Dluzen D; Li G; Tacelosky D; Moreau M; Liu DX
J Biol Chem; 2011 Mar; 286(9):7705-13. PubMed ID: 21212266
[TBL] [Abstract][Full Text] [Related]
15. CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells.
Pan YC; Li CF; Ko CY; Pan MH; Chen PJ; Tseng JT; Wu WC; Chang WC; Huang AM; Sterneck E; Wang JM
Clin Cancer Res; 2010 Dec; 16(23):5770-80. PubMed ID: 20971808
[TBL] [Abstract][Full Text] [Related]
16. Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5.
Angelastro JM; Canoll PD; Kuo J; Weicker M; Costa A; Bruce JN; Greene LA
Oncogene; 2006 Feb; 25(6):907-16. PubMed ID: 16170340
[TBL] [Abstract][Full Text] [Related]
17. Fasting induced up-regulation of activating transcription factor 5 in mouse liver.
Shimizu YI; Morita M; Ohmi A; Aoyagi S; Ebihara H; Tonaki D; Horino Y; Iijima M; Hirose H; Takahashi S; Takahashi Y
Life Sci; 2009 Jun; 84(25-26):894-902. PubMed ID: 19376136
[TBL] [Abstract][Full Text] [Related]
18. Regulation of mouse chondrocyte differentiation by CCAAT/enhancer-binding proteins.
Okuma T; Hirata M; Yano F; Mori D; Kawaguchi H; Chung UI; Tanaka S; Saito T
Biomed Res; 2015; 36(1):21-9. PubMed ID: 25749148
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer.
Zhou Y; Liu F; Xu Q; Yang B; Li X; Jiang S; Hu L; Zhang X; Zhu L; Li Q; Zhu X; Shao H; Dai M; Shen Y; Ni B; Wang S; Zhang Z; Teng Y
Oncogene; 2020 Aug; 39(34):5633-5648. PubMed ID: 32661323
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Expression of CEBP Genes by Variably Expressed Vitamin D Receptor and Retinoic Acid Receptor α in Human Acute Myeloid Leukemia Cell Lines.
Marchwicka A; Marcinkowska E
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
